ADVISORY TEAM EXPERTISE

Advisory Board Overview

Scientific & Drug Development Leadership

Preclinical Toxicology & Safety Strategy

Preclinical strategy and safety assessment
IND-enabling toxicology programs
Risk assessment for emerging therapeutics
Regulatory toxicology strategy

Clinical Pharmacology & Translational Development

Clinical pharmacology strategy
IND / NDA development pathways
Phase I/II clinical design
Model-informed drug development
Translational medicine strategy

Pharmaceutical Development & Manufacturing

Sterile Drug Product & Biologics Manufacturing

Complex drug product development
Sterile manufacturing strategy
Biologics and injectable formulation
Manufacturing scale-up and commercialization

Lyophilization & Biologics Process Engineering

Lyophilization process design
Biologics manufacturing scale-up
Technology transfer
CMC development risk mitigation

Preclinical Operations & Research Infrastructure

Preclinical Research Operations & Vivarium Strategy

Preclinical infrastructure strategy
Vivarium design and operations
AAALAC / IACUC compliance
Translational research operations

Quality, Regulatory & Compliance

Global Quality Systems & Regulatory Compliance

Global GMP compliance strategy
Regulatory inspection readiness
Quality system design and remediation
Pharmaceutical supply chain compliance

FDA Regulatory Law & Policy

FDA regulatory strategy
Compliance and enforcement risk
Federal regulatory policy
Market authorization frameworks

Quality Operations & Analytical Sciences

Global Quality Control & Analytical Operations

QC laboratory operations
Analytical strategy for commercialization
Stability and release testing programs
Operational excellence in regulated labs

Validation, CQV & GMP Operations

GMP manufacturing readiness
Equipment and facility validation
Technology transfer
Quality system optimization

Corporate Strategy & Commercialization

Corporate Strategy, M&A & CDMO Industry

Corporate strategy and partnerships
M&A and strategic transactions
CDMO market strategy
Commercial expansion

Diagnostics Platform Development & Commercialization

Diagnostics platform commercialization
Regulatory approval pathways (FDA / CE-IVD)
Global diagnostics market strategy
Operational turnaround of development programs

Brand Strategy & Venture-Stage Growth

Venture brand strategy
Product positioning for complex technologies
Investor communications
Go-to-market messaging

Healthcare Commercialization & Sales Strategy

Medtech commercialization
Hospital market access
Sales channel development
Strategic account growth

Number of companies: 6
Number of contacts: 10